272 related articles for article (PubMed ID: 15336607)
1. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats.
Weber K; Kaschig C; Erben RG
Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607
[TBL] [Abstract][Full Text] [Related]
2. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
3. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
[TBL] [Abstract][Full Text] [Related]
4. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
[TBL] [Abstract][Full Text] [Related]
5. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
[TBL] [Abstract][Full Text] [Related]
6. [Effects of 1 alpha(OH)D3 on trabecular and cortical bone in ovariectomized rats].
Xia W; Meng X; Xing X; Hu Y; Liu H; Zhou X; Qiu G; Yang X; Shen V; Wu D; Dempster D; Lindsay R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):543-7. PubMed ID: 12903400
[TBL] [Abstract][Full Text] [Related]
7. Alfacalcidol restores cancellous bone in ovariectomized rats.
Li M; Healy DR; Simmons HA; Ke HZ; Thompson DD
J Musculoskelet Neuronal Interact; 2003 Mar; 3(1):39-46. PubMed ID: 15758364
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic effects of 1,24,25-trihydroxyvitamin D3 on ovariectomy-induced cancellous bone loss in the rat.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):434-40. PubMed ID: 9115161
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicotine on bone and calciotropic hormones in aged ovariectomized rats.
Iwaniec UT; Haynatzki GR; Fung YK; Akhter MP; Haven MC; Cullen DM
J Musculoskelet Neuronal Interact; 2002 Sep; 2(5):469-78. PubMed ID: 15758416
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
Erben RG; Bromm S; Stangassinger M
Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
[TBL] [Abstract][Full Text] [Related]
12. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
13. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
Bonnet N; Laroche N; Vico L; Dolleans E; Benhamou CL; Courteix D
J Pharmacol Exp Ther; 2006 Sep; 318(3):1118-27. PubMed ID: 16740619
[TBL] [Abstract][Full Text] [Related]
14. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM
J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480
[TBL] [Abstract][Full Text] [Related]
15. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
16. A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia.
Sato M; Lu J; Iturria S; Stayrook KR; Burris LL; Zeng QQ; Schmidt A; Barr RJ; Montrose-Rafizadeh C; Bryant HU; Ma YL
J Bone Miner Res; 2010 Jun; 25(6):1326-36. PubMed ID: 20200930
[TBL] [Abstract][Full Text] [Related]
17. Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3.
Gal-Moscovici A; Gal M; Popovtzer MM
Eur J Clin Invest; 2005 Jun; 35(6):375-9. PubMed ID: 15948898
[TBL] [Abstract][Full Text] [Related]
18. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
Oxlund H; Andreassen TT
Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
[TBL] [Abstract][Full Text] [Related]
20. Cortical bone loss in androgen-deficient aged male rats is mainly caused by increased endocortical bone remodeling.
Reim NS; Breig B; Stahr K; Eberle J; Hoeflich A; Wolf E; Erben RG
J Bone Miner Res; 2008 May; 23(5):694-704. PubMed ID: 18433303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
